Skip to main content

Healthcare Analytical Testing Services to Reflect Impressive Growth in Biotechnology and Pharmaceuticals Sector


In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of healthcare analytical testing services market.

Pharmaceuticals and Biotechnology Sector to Dominate The Industry:

Pharmaceutical & biopharmaceutical companies hold the largest share in the market. The largest share of this segment in the market can be attributed to the tremendous amount of analytical testing required to support a product from discovery, development, and clinical trials, through manufacturing and marketing.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833

The batch-release testing segment is projected to grow at the highest CAGR during the forecast period. Within the batch-release testing services segment, the dissolution testing services market is projected to grow at the highest growth rate during the forecast period.

North America to Dominate the Healthcare Analytical Testing Services Market:

North America held the largest share in the healthcare analytical testing services market in 2019. This dominance of North America in this market is due to the presence of many pharmaceutical and biopharmaceutical companies, high investments and rising focus on the biosimilars & biologics segment, and high allocation to R&D. The Asia Pacific market is expected to register the highest growth during the forecast period, primarily due to the lower production costs and growing favorability of the regulatory environment.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=108923833

Key Players in Healthcare Analytical Testing Services Market:

The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), LabCorp (US), SGS (Switzerland), Charles River Laboratories (US), WuXi PharmaTech (China), PPD (US), Element Materials Technology (UK), Pace Analytical (US), Intertek (UK), Merck KGAA (Germany), Source BioScience (UK), Almac Group (Ireland), ICON (Ireland), Frontage Labs (US), STERIS PLC (US), PRA Health Sciences (US), Syneos Health (US), Medpace Holdings (US), LGC Limited (UK), and Anacura (Belgium).

Comments

Popular posts from this blog

A Best e-Commerce Platform for B2B & B2C Businesses – STORM

  Storm eCommerce platform is one of the modern, scalable, and advanced, eCommerce platforms, designed for online merchants who deal with several transactions. Smaller online retailers with rapidly growing business may also choose this product. Developed in 2008, Storm Commerce has turned out to be a useful platform with eCommerce solutions. Storm Commerce is mainly equipped with B2B functionalities, automated technologies, and user-friendly interface. USP of This Platform: Storm eCommerce platform is a seamless platform and its customized solutions can manage several deals of B2B and B2C businesses. The automation technologies have helped businesses to ensure an increased profitability, higher performance, and smarter workflows. As one of the cloud SaaS solutions, Storm is valuable for its performance and high capacity. The open APIs of Storm enable users to integrate a CMS and different other systems. It helps in developing omni-channel commerce with its features and functionalities.

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, followed by E

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The successful